Chronic Kidney Disease: Underlying Molecular Mechanisms

• Pubblicazione: MDPI - Multidisciplinary Digital Publishing Institute, 2023
• Descrizione fisica: 1 online resource (216 p.)
• Soggetto topico: Medicine and Nursing; Pharmacology
• Soggetto non controllato: adipose tissue browning; arsenic; biomarkers; cachexia; cadmium; cellular injury; children; chronic kidney disease; CKD; developmental origins of health and disease (DOHaD); end-stage renal disease (ESRD); exercise; fibrosis; FSGS; growth hormone; gut microbiota; heavy metals; hypertension; inflammation; kidney; lipolysis; lymphatics; Marinobufagenin (MBG); mass spectrometry; MCD; mercury; muscle function; muscle mass; n/a; nervous and immune systems; NKCC1 transporter; NZO mice; oxidative stress; podocyte dysfunction; prebiotics; probiotics; reactive oxygen species (ROS); SH045; short-chain fatty acids; skeletal muscle wasting; sodium; TNF-alpha; TNFR; trimethylamine-N-oxide; TRPC6; uremic toxins; urine proteome; UUO
• Sommario/riassunto: Chronic kidney disease (CKD) is a worldwide public health problem that must be addressed. The global increase in CKD prevalence is associated with an increase in conventional disease risk factors (e.g., diabetes and hypertension), which may be exacerbated by additional variables such as environmental and occupational exposure to toxic compounds. Authors contributed to this Special Issue by highlighting the finding of potential novel biomarkers of the disease and more effective therapy alternatives, as well as works that enhance the understanding of CKD pathogenesis and its related complications.
• Altri titoli varianti: Chronic Kidney Disease
• Titolo autorizzato: Chronic Kidney Disease: Underlying Molecular Mechanisms
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910743274103321
• Lo trovi qui: Univ. Federico II